• Giancarlo Logroscino, Dale C Hesdorffer, Gregory Cascino, W Allen Hauser, Alessandra Coeytaux, Bruna Galobardes, Alfredo Morabia, and Pierre Jallon.
• Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. glogrosc@hsph.harvard.edu
• Epilepsia. 2005 Jan 1;46 Suppl 11:46-8.

ObjectiveIn the last decade several studies have been published on incidence, etiology, and prognosis of status epilepticus (SE) with population-based data from the United States and Europe. The aim of this review is to summarize the available information on the epidemiology of SE and to outline the sources of the variability in reported mortality after SE.MethodsComparison of mortality studies in SE from the United States and Europe.ResultsThe incidence of SE is lower in Europe (9.9-15.8/10,000) than in the United States (18.3-41/100,000). The overall mortality after SE is similar in the two U.S. studies: the case fatality is 21% in Rochester, and 22% in Richmond. All European studies excluded SE after anoxic encephalopathy following cardiac arrest. This exclusion may partly explain the lower case fatality (around 10%) found in two of the European studies. The study from Bologna showed the highest case fatality (33%) even after exclusion of anoxic encephalopathy. The mortality in acute symptomatic SE was higher than for other forms of SE across all studies.ConclusionsShort-term mortality after SE occurs mainly in the acute symptomatic group. Based on published data, it is not clear if differences in early management and medical treatment have any impact on prognosis or whether the differences can be attributed only to differences in distribution of the underlying causes in acute symptomatic SE. Future studies should address this issue.

22 keywords...

hide…